Ballotta L, Trisolini S M, Iori A P, La Rocca U, Micozzi A, Gentile G, De Giacomo T, Guarini A, Foà R, Capria S
Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Department of Cardiovascular and Thoracic Surgery "Paride Stefanini", Sapienza University, Policlinico Umberto I, Rome, Italy.
Case Rep Hematol. 2020 Aug 25;2020:8893185. doi: 10.1155/2020/8893185. eCollection 2020.
The occurrence of acute myeloid leukemia (AML) within six months from a diagnosis of breast cancer (BC) is rarely reported in the literature, and it is associated with a poor prognosis. We report herein the case of a 40-year-old woman referred to our centre affected by BC and simultaneous AML. The patient proved refractory to first line therapy and achieved complete remission (CR) with a clofarabine-based regimen followed by allogeneic stem cell transplantation (ASCT). Both during salvage chemotherapy and after ASCT, the patient presented severe infectious complications ( acute cholecistytis and pneumonia, respectively) treated with surgery, and currently she is alive in CR for both diseases after 29 months of follow-up. The case highlights the importance of a diagnostic assessment of any unexplained cytopenia in association with solid neoplasia under treatment, underlining the feasibility and priority of a timely treatment of the haematological neoplasm in order to achieve long-term survival.
乳腺癌(BC)诊断后六个月内发生急性髓系白血病(AML)的情况在文献中鲜有报道,且其预后较差。我们在此报告一例40岁女性患者,该患者被转诊至我院,患有BC并同时患有AML。患者一线治疗无效,采用基于氯法拉滨的方案并序贯异基因干细胞移植(ASCT)后实现完全缓解(CR)。在挽救性化疗期间及ASCT后,患者分别出现严重感染并发症(急性胆囊炎和肺炎),经手术治疗,目前在随访29个月后,两种疾病均处于CR状态且存活。该病例凸显了对正在接受治疗的实体瘤患者出现的任何不明原因血细胞减少进行诊断评估的重要性,强调了及时治疗血液肿瘤以实现长期生存的可行性和优先性。